IBDEI0R8 ; ; 12-AUG-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,13433,0)
 ;;=465.9^^87^834^65
 ;;^UTILITY(U,$J,358.3,13433,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13433,1,4,0)
 ;;=4^465.9
 ;;^UTILITY(U,$J,358.3,13433,1,5,0)
 ;;=5^Upper Resp Tract Infection,Multi or Unspec Sites
 ;;^UTILITY(U,$J,358.3,13433,2)
 ;;=^269878
 ;;^UTILITY(U,$J,358.3,13434,0)
 ;;=703.8^^87^834^26
 ;;^UTILITY(U,$J,358.3,13434,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13434,1,4,0)
 ;;=4^703.8
 ;;^UTILITY(U,$J,358.3,13434,1,5,0)
 ;;=5^Disease of Nail,Oth Spec Disease/Dystrophia Unguium
 ;;^UTILITY(U,$J,358.3,13434,2)
 ;;=^271926
 ;;^UTILITY(U,$J,358.3,13435,0)
 ;;=780.52^^87^834^37
 ;;^UTILITY(U,$J,358.3,13435,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13435,1,4,0)
 ;;=4^780.52
 ;;^UTILITY(U,$J,358.3,13435,1,5,0)
 ;;=5^Insomnia
 ;;^UTILITY(U,$J,358.3,13435,2)
 ;;=^332924
 ;;^UTILITY(U,$J,358.3,13436,0)
 ;;=600.01^^87^834^12
 ;;^UTILITY(U,$J,358.3,13436,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13436,1,4,0)
 ;;=4^600.01
 ;;^UTILITY(U,$J,358.3,13436,1,5,0)
 ;;=5^BPH with Obstruction (LUTS)
 ;;^UTILITY(U,$J,358.3,13436,2)
 ;;=^334256
 ;;^UTILITY(U,$J,358.3,13437,0)
 ;;=346.90^^87^834^43
 ;;^UTILITY(U,$J,358.3,13437,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13437,1,4,0)
 ;;=4^346.90
 ;;^UTILITY(U,$J,358.3,13437,1,5,0)
 ;;=5^Migraine, Unspec w/o Intract Migraine w/o Status Migrainosus
 ;;^UTILITY(U,$J,358.3,13437,2)
 ;;=^336879
 ;;^UTILITY(U,$J,358.3,13438,0)
 ;;=607.84^^87^834^36
 ;;^UTILITY(U,$J,358.3,13438,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13438,1,4,0)
 ;;=4^607.84
 ;;^UTILITY(U,$J,358.3,13438,1,5,0)
 ;;=5^Impotence of Organic Origin
 ;;^UTILITY(U,$J,358.3,13438,2)
 ;;=^270441
 ;;^UTILITY(U,$J,358.3,13439,0)
 ;;=173.91^^87^834^14
 ;;^UTILITY(U,$J,358.3,13439,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13439,1,4,0)
 ;;=4^173.91
 ;;^UTILITY(U,$J,358.3,13439,1,5,0)
 ;;=5^Basal Cell CA of Skin,Site Unspec
 ;;^UTILITY(U,$J,358.3,13439,2)
 ;;=^340491
 ;;^UTILITY(U,$J,358.3,13440,0)
 ;;=173.92^^87^834^60
 ;;^UTILITY(U,$J,358.3,13440,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13440,1,4,0)
 ;;=4^173.92
 ;;^UTILITY(U,$J,358.3,13440,1,5,0)
 ;;=5^Squamous Cell CA of Skin,Site Unspec
 ;;^UTILITY(U,$J,358.3,13440,2)
 ;;=^340492
 ;;^UTILITY(U,$J,358.3,13441,0)
 ;;=790.6^^87^834^39
 ;;^UTILITY(U,$J,358.3,13441,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13441,1,4,0)
 ;;=4^790.6
 ;;^UTILITY(U,$J,358.3,13441,1,5,0)
 ;;=5^Liver Enzymes,Elevated
 ;;^UTILITY(U,$J,358.3,13441,2)
 ;;=^87228
 ;;^UTILITY(U,$J,358.3,13442,0)
 ;;=272.2^^87^834^32
 ;;^UTILITY(U,$J,358.3,13442,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13442,1,4,0)
 ;;=4^272.2
 ;;^UTILITY(U,$J,358.3,13442,1,5,0)
 ;;=5^Hyperlipidemia,Mixed
 ;;^UTILITY(U,$J,358.3,13442,2)
 ;;=^78424
 ;;^UTILITY(U,$J,358.3,13443,0)
 ;;=272.4^^87^834^31
 ;;^UTILITY(U,$J,358.3,13443,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13443,1,4,0)
 ;;=4^272.4
 ;;^UTILITY(U,$J,358.3,13443,1,5,0)
 ;;=5^Hyperlipidemia NEC/NOS
 ;;^UTILITY(U,$J,358.3,13443,2)
 ;;=^87281
 ;;^UTILITY(U,$J,358.3,13444,0)
 ;;=244.9^^87^834^34
 ;;^UTILITY(U,$J,358.3,13444,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13444,1,4,0)
 ;;=4^244.9
 ;;^UTILITY(U,$J,358.3,13444,1,5,0)
 ;;=5^Hypothyroidism NOS
 ;;^UTILITY(U,$J,358.3,13444,2)
 ;;=^123752
 ;;^UTILITY(U,$J,358.3,13445,0)
 ;;=173.90^^87^834^42
 ;;^UTILITY(U,$J,358.3,13445,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13445,1,4,0)
 ;;=4^173.90
 ;;^UTILITY(U,$J,358.3,13445,1,5,0)
 ;;=5^Mal Neoplasm of Skin,Unspec/Site Unspec
 ;;^UTILITY(U,$J,358.3,13445,2)
 ;;=^340605
 ;;^UTILITY(U,$J,358.3,13446,0)
 ;;=288.09^^87^835^1
